Among 43,917 patients undergoing primary THA from 1970 to 2015, we identified 50 THAs performed in 29 patients with SED; 21 patients underwent bilateral THA (none simultaneous). There were 16 females and 13 males; mean age, body mass index, and height were 39 years, 28.7 kg/m2, and 145 cm, respectively. All patients were able to ambulate prior to the THA. Mean follow-up was 11 years (range 2-38).
Mean implant survival for primary THA in SED patients at the 5, 10, and 20-year time points was 96%, 85%, and 55%, respectively. Thirteen patients required revision THA, most commonly for polyethylene wear (n = 6) and aseptic loosening (n = 5), and 4 additional patients underwent nonrevision reoperations. Prior to surgery, 90% of patients had severe or moderate pain, which was reduced to 8% of patients postoperatively (P < .001). Mean Harris Hip Score improved from 47 to 87 (P < .001). Prior to surgery, 64% of patients required gait aids, which reduced to 34% postoperatively (P < .001).
THA provided significant pain reduction and improvement in function, with a majority of patients ambulating independently following the procedure. There was a high incidence of complications following THA in patients with SED, most commonly secondary to polyethylene wear and osteolysis from conventional polyethylene and historical implants.
Level IV, Therapy.
在1970年至2015年接受原发性THA的43,917例患者中,我们确定了29例SED患者中的50例THA;21例患者接受了双侧THA(无同时)。有16名女性和13名男性;平均年龄,身体质量指数,身高39岁,28.7千克/平方米,145厘米,分别。所有患者都能够在THA之前走动。平均随访时间为11年(范围2-38)。
在5、10和20年时间点,SED患者原发性THA的平均植入物存活率为96%,85%,55%,分别。13名患者需要翻修THA,最常见的是聚乙烯磨损(n=6)和无菌性松动(n=5),另外4例患者接受了非修正性再次手术.手术前,90%的患者有重度或中度疼痛,术后患者减少到8%(P<.001)。平均Harris髋关节评分从47分提高到87分(P<.001)。手术前,64%的患者需要步态辅助,术后降至34%(P<.001)。
THA显著减轻疼痛,改善功能,大多数患者在手术后独立行走。在SED患者中,THA后并发症的发生率很高,最常见的继发性聚乙烯磨损和骨溶解从传统的聚乙烯和历史植入物。
IV级,治疗。